Literature DB >> 6746719

The metabolism of N-nitrosomethylaniline.

H M Pylypiw, J R Zubroff, P N Magee, G W Harrington.   

Abstract

The distribution in the body, rate of disappearance from organs, tissues, and blood, and excretion in the urine of N-nitrosomethylaniline (NMA, N-nitrosophenylmethylamine) was investigated after various single doses given IP to rats. The compound was distributed fairly evenly throughout the body with no preferential concentration in the esophagus, its target organ for carcinogenicity. The high lipid solubility of NMA did not lead to any increased accumulation in adipose tissue. According to its rate of disappearance from circulating blood and tissues of rats, and from the whole bodies of mice after injection, NMA appeared to be rapidly metabolized. Methylaniline (MA), the parent amine, was found in the urine after administration of NMA but the amounts present were small relative to the dose of NMA. Administered MA was mainly excreted unchanged in the urine, suggesting that denitrosation of NMA could only be a minor metabolic pathway. No volatile nitrosamines were found in the urine or blood of rats given NMA, indicating that little, if any, transnitrosation could have occurred to yield these compounds.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6746719     DOI: 10.1007/BF00390975

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  8 in total

1.  [Organotropic carcinogenic effects of 65 various N-nitroso- compounds on BD rats].

Authors:  H Druckrey; R Preussmann; S Ivankovic; D Schmähl
Journal:  Z Krebsforsch       Date:  1967

Review 2.  Carcinogenic nitroso compounds.

Authors:  P N Magee; J M Barnes
Journal:  Adv Cancer Res       Date:  1967       Impact factor: 6.242

3.  Determination of N-nitroso-N-methylaniline in whole blood, serum, and urine.

Authors:  H M Pylypiw; G W Harrington
Journal:  Anal Chem       Date:  1981-12       Impact factor: 6.986

4.  Animal Species in which N-nitroso compounds induce cancer.

Authors:  P Bogovski; S Bogovski
Journal:  Int J Cancer       Date:  1981       Impact factor: 7.396

5.  Nmethyl-N-nitrosourea as a strong topical carcinogen when painted on skin of rodents.

Authors:  A Graffi; A Hoffmann; M Schütt
Journal:  Nature       Date:  1967-05-06       Impact factor: 49.962

6.  Alkylation of DNA and tissue specificity in nitrosamine carcinogenesis.

Authors:  R Montesano
Journal:  J Supramol Struct Cell Biochem       Date:  1981

7.  Induction of a high affinity nitrosamine demethylase in rat liver microsomes by acetone and isopropanol.

Authors:  Y Y Tu; R Peng; Z F Chang; C S Yang
Journal:  Chem Biol Interact       Date:  1983-06       Impact factor: 5.192

8.  Induction of squamous carcinoma of the lung and of the stomach and oesophagus by diazomethane and N-methyl-N-nitroso-urethane, respectively.

Authors:  R SCHOENTAL; P N MAGEE
Journal:  Br J Cancer       Date:  1962-03       Impact factor: 7.640

  8 in total
  4 in total

1.  Nitrosamine exposure causes insulin resistance diseases: relevance to type 2 diabetes mellitus, non-alcoholic steatohepatitis, and Alzheimer's disease.

Authors:  Ming Tong; Alexander Neusner; Lisa Longato; Margot Lawton; Jack R Wands; Suzanne M de la Monte
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

2.  Mechanisms of nitrosamine-mediated neurodegeneration: potential relevance to sporadic Alzheimer's disease.

Authors:  Suzanne M de la Monte; Ming Tong
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

3.  Early limited nitrosamine exposures exacerbate high fat diet-mediated type 2 diabetes and neurodegeneration.

Authors:  Ming Tong; Lisa Longato; Suzanne M de la Monte
Journal:  BMC Endocr Disord       Date:  2010-03-19       Impact factor: 2.763

4.  Nitrosamine exposure exacerbates high fat diet-mediated type 2 diabetes mellitus, non-alcoholic steatohepatitis, and neurodegeneration with cognitive impairment.

Authors:  Suzanne M de la Monte; Ming Tong; Margot Lawton; Lisa Longato
Journal:  Mol Neurodegener       Date:  2009-12-24       Impact factor: 14.195

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.